FTC targets WPATH amid coordinated attacks on trans healthcare: systemic erosion of medical autonomy and evidence-based care
Original framing: “Federal Trade Commission sues leading transgender health group” — The Guardian - World
The medicalization of transgender identities began in the 20th century with pathologizing diagnoses like 'gender identity disorder,' which justified coercive treatments. WPATH emerged in 1979 to establish ethical standards, countering earlier unregulated practices that harmed patients. This lawsuit echoes historical attacks on medical autonomy, such as the anti-vaccine movement or attacks on abortion providers, where state power overrides scientific consensus.
The FTC’s lawsuit against WPATH is not merely a consumer protection issue but a coordinated assault on transgender autonomy, leveraging regulatory power to enforce ideological conformity.
This strategy mirrors historical patterns of medical gatekeeping against marginalized bodies, from the pathologization of homosexuality to the suppression of indigenous knowledge systems. The erasure of non-Western gender frameworks—such as Two-Spirit or Hijra traditions—reveals a colonial continuity in which Western institutions police bodily diversity under the guise of science. Meanwhile, the economic and political incentives driving these attacks remain obscured, with pharmaceutical and insurance industries poised to profit from alternative treatments. The solution lies in dismantling the regulatory capture of healthcare, centering marginalized voices in medical governance, and reclaiming gender diversity as a natural and sacred aspect of human existence across cultures.